Novartis Unveils New Strategy Based On Eight Multibillion- Dollar Brands

Novartis Unveils New Strategy Based On Eight Multibillion- Dollar Brands

ZURICH (Reuters) -Novartis unveiled a new strategy on Thursday based on eight big drug brands as the pharmaceuticals maker reshapes itself following the decision to spin off its underperforming generics business Sandoz. Ahead of an investor event, the Swiss company said the currently in-market brands – Cosentyx, Entresto, Zolgensma, Kisqali, Kesimpta, Leqvio, Pluvicto and Scemblix…

Read More

Powell’s stark message: Inflation fight may cause recession

WASHINGTON (AP) — The Federal Reserve delivered its bluntest reckoning Wednesday of what it will take to finally tame painfully high inflation: Slower growth, higher unemployment and potentially a recession. Speaking at a news conference, Chair Jerome Powell acknowledged what many economists have been saying for months: That the Fed’s goal of engineering a “soft…

Read More